Recombinant Bone Morphogenetic Protein Linked to Reduce Risk of Reoperation Following Spine Fusion for Adult Scoliosis
Fuente
Este artículo es originalmente publicado en:
https://www.spineuniverse.com/professional/news/recombinant-bone-morphogenetic-protein-linked-reduce-risk-reoperation-following-0
De:
Comments by Baron S. Lonner, MD and Eeric Truumees, MD
;
Peer Reviewed
Todos los derechos reservados para:
© 1999-2018 Vertical Health, LLC
This information is not designed to replace a physician’s independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions or back problem. SpineUniverse does not provide medical advice, diagnosis or treatment. Use of the SpineUniverse.com site is conditional upon your acceptance of our User Agreement
Recombinant Bone #Morphogenetic Protein Linked to Reduce Risk of Reoperation Following Spine Fusion for Adult #Scoliosis https://t.co/3Pjbutoinr pic.twitter.com/uq6yq84JZI
— SpineUniverse (@SpineUniverse) 26 de junio de 2018